The global Propofol and Ciprofol Injections market was valued at US$ 1491 million in 2025 and is anticipated to reach US$ 2016 million by 2032, at a CAGR of 4.4% from 2026 to 2032.

Propofol and Ciprofol Injections Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Propofol and Ciprofol Injections competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Propofol and ciprofol injections are intravenous short-acting sedative–hypnotic anesthetics used for general anesthesia and procedural sedation. Propofol is supplied as a white oil-in-water injectable emulsion because the drug is poorly water-soluble.

Upstream, the supply chain combines API synthesis and parenteral lipid-emulsion manufacturing with pharmaceutical excipients (e.g., soybean oil, egg lecithin/phospholipids, glycerol. Downstream, these injections are primarily used in hospitals and ambulatory procedure settings (operating rooms/anesthesia departments, endoscopy units, and in some regions ICU sedation), with strict requirements on aseptic handling and single-patient use because lipid emulsions can support microbial growth and are labeled accordingly (including allergy considerations related to egg/soy components in some products).

In 2025, global sales of propofol and ciprofol injections reached approximately 392 million units, with an average global market price of around US$ 3.8/unit. Production capacity varies significantly among manufacturers, with gross profit margins ranging from approximately 50% to 70%.

Propofol and ciprofol injections are short-acting IV sedative–hypnotics used across anesthesia induction/maintenance, procedural sedation (such as endoscopy), and parts of ICU sedation practice. As ambulatory surgery and outpatient procedures expand and anesthesia becomes more titration-driven, healthcare providers increasingly value agents with rapid onset, fast recovery, and controllable depth of sedation—while also paying close attention to hemodynamic fluctuation, respiratory depression, and the patient experience of injection pain, leaving room for product differentiation and formulation optimization.

On the supply side, competition is shaped not only by the API but by the quality system behind lipid-emulsion injectables: choices in the oil phase and emulsifiers (e.g., soybean oil and egg phospholipids) and the microbial-growth control strategy can influence emulsion stability, contamination risk management, and ease of clinical use. Labels for propofol emulsions commonly emphasize strict aseptic handling, single-patient use, and allergy considerations tied to egg/soy components, so reliable supply, batch-to-batch consistency, and documentation/compliance capability often determine access to top-tier hospitals and high-throughput endoscopy chains.

Looking ahead, propofol is highly genericized in many markets, making procurement and cost efficiency central. In parallel, “improved” molecules positioned for potentially smoother hemodynamics and lower injection pain—such as ciprofol in regions where it is approved—are being adopted more rapidly, creating a two-layer structure of high-volume generics plus next-generation alternatives. Building defensible advantage typically requires a combination of clinical evidence, control over critical excipients, robust aseptic fill–finish capabilities, and deep linkage to high-frequency clinical scenarios like anesthesia and GI endoscopy.

This report delivers a comprehensive overview of the global Propofol and Ciprofol Injections market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Propofol and Ciprofol Injections. The Propofol and Ciprofol Injections market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Propofol and Ciprofol Injections market comprehensively. Regional market sizes by Type, by Application, by Concentration, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Propofol and Ciprofol Injections manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Propofol and Ciprofol Injections Market Report

Report Metric	Details
Report Name	Propofol and Ciprofol Injections Market
Accounted market size in 2025	US$ 1491 million
Forecasted market size in 2032	US$ 2016 million
CAGR	4.4%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Propofol Injections Ciprofol Injections
Segment by Concentration	1% 2% Other
Segment by Packaging	10 mL 20 mL 50 mL 100 mL
by Application	General Anesthesia Medical Procedures Sedation Mechanical Ventilation Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Fresenius Kabi, Pfizer, B. Braun, Sagent Pharmaceuticals, Dr. Reddy's Laboratories, Rusoma, Centurion Healthcare, Wellona Pharma, Hikma Pharmaceuticals, Avet Pharmaceuticals, Xi’an Libang Pharmaceutical, Guangdong Jiabo Pharmaceutical, Sichuan Biokin Pharmaceutical, Sichuan Kelun Pharmaceutical, Jiangsu Nhwa Pharmaceutical, Jiangsu Yingke Biopharmaceutical, Haisco Pharmaceutical Group
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Concentration, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Propofol and Ciprofol Injections manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Propofol and Ciprofol Injections sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Propofol and Ciprofol Injections Market growing?

Ans: The Propofol and Ciprofol Injections Market witnessing a CAGR of 4.4% during the forecast period 2026-2032.

What is the Propofol and Ciprofol Injections Market size in 2032?

Ans: The Propofol and Ciprofol Injections Market size in 2032 will be US$ 2016 million.

Who are the main players in the Propofol and Ciprofol Injections Market report?

Ans: The main players in the Propofol and Ciprofol Injections Market are Fresenius Kabi, Pfizer, B. Braun, Sagent Pharmaceuticals, Dr. Reddy's Laboratories, Rusoma, Centurion Healthcare, Wellona Pharma, Hikma Pharmaceuticals, Avet Pharmaceuticals, Xi’an Libang Pharmaceutical, Guangdong Jiabo Pharmaceutical, Sichuan Biokin Pharmaceutical, Sichuan Kelun Pharmaceutical, Jiangsu Nhwa Pharmaceutical, Jiangsu Yingke Biopharmaceutical, Haisco Pharmaceutical Group

What are the Application segmentation covered in the Propofol and Ciprofol Injections Market report?

Ans: The Applications covered in the Propofol and Ciprofol Injections Market report are General Anesthesia, Medical Procedures Sedation, Mechanical Ventilation, Other

What are the Type segmentation covered in the Propofol and Ciprofol Injections Market report?

Ans: The Types covered in the Propofol and Ciprofol Injections Market report are Propofol Injections, Ciprofol Injections

1 Propofol and Ciprofol Injections Market Overview

1.1 Product Definition

1.2 Propofol and Ciprofol Injections by Type

1.2.1 Global Propofol and Ciprofol Injections Market Value by Type: 2025 vs 2032

1.2.2 Propofol Injections

1.2.3 Ciprofol Injections

1.3 Propofol and Ciprofol Injections by Concentration

1.3.1 Global Propofol and Ciprofol Injections Market Value by Concentration: 2025 vs 2032

1.3.2 1%

1.3.3 2%

1.3.4 Other

1.4 Propofol and Ciprofol Injections by Packaging

1.4.1 Global Propofol and Ciprofol Injections Market Value by Packaging: 2025 vs 2032

1.4.2 10 mL

1.4.3 20 mL

1.4.4 50 mL

1.4.5 100 mL

1.5 Propofol and Ciprofol Injections by Application

1.5.1 Global Propofol and Ciprofol Injections Market Value by Application: 2025 vs 2032

1.5.2 General Anesthesia

1.5.3 Medical Procedures Sedation

1.5.4 Mechanical Ventilation

1.5.5 Other

1.6 Global Propofol and Ciprofol Injections Market Size Estimates and Forecasts

1.6.1 Global Propofol and Ciprofol Injections Revenue 2021–2032

1.6.2 Global Propofol and Ciprofol Injections Sales 2021–2032

1.6.3 Global Propofol and Ciprofol Injections Market Average Price (2021–2032)

1.7 Assumptions and Limitations

2 Propofol and Ciprofol Injections Market Competition by Manufacturers

2.1 Global Propofol and Ciprofol Injections Sales Market Share by Manufacturers (2021–2026)

2.2 Global Propofol and Ciprofol Injections Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Propofol and Ciprofol Injections Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Propofol and Ciprofol Injections, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Propofol and Ciprofol Injections, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Propofol and Ciprofol Injections, Product Types and Applications

2.7 Global Key Manufacturers of Propofol and Ciprofol Injections, Date of Entry into the Industry

2.8 Global Propofol and Ciprofol Injections Market Competitive Situation and Trends

2.8.1 Global Propofol and Ciprofol Injections Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Propofol and Ciprofol Injections Players Market Share by Revenue

2.8.3 Global Propofol and Ciprofol Injections Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Propofol and Ciprofol Injections Market Scenario by Region

3.1 Global Propofol and Ciprofol Injections Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Propofol and Ciprofol Injections Sales by Region: 2021–2032

3.2.1 Global Propofol and Ciprofol Injections Sales by Region: 2021–2026

3.2.2 Global Propofol and Ciprofol Injections Sales by Region: 2027–2032

3.3 Global Propofol and Ciprofol Injections Revenue by Region: 2021–2032

3.3.1 Global Propofol and Ciprofol Injections Revenue by Region: 2021–2026

3.3.2 Global Propofol and Ciprofol Injections Revenue by Region: 2027–2032

3.4 North America Propofol and Ciprofol Injections Market Facts & Figures by Country

3.4.1 North America Propofol and Ciprofol Injections Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Propofol and Ciprofol Injections Sales by Country (2021–2032)

3.4.3 North America Propofol and Ciprofol Injections Revenue by Country (2021–2032)

3.4.4 United States

3.4.5 Canada

3.5 Europe Propofol and Ciprofol Injections Market Facts & Figures by Country

3.5.1 Europe Propofol and Ciprofol Injections Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Propofol and Ciprofol Injections Sales by Country (2021–2032)

3.5.3 Europe Propofol and Ciprofol Injections Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Propofol and Ciprofol Injections Market Facts & Figures by Region

3.6.1 Asia Pacific Propofol and Ciprofol Injections Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Propofol and Ciprofol Injections Sales by Region (2021–2032)

3.6.3 Asia Pacific Propofol and Ciprofol Injections Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Propofol and Ciprofol Injections Market Facts & Figures by Country

3.7.1 Latin America Propofol and Ciprofol Injections Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Propofol and Ciprofol Injections Sales by Country (2021–2032)

3.7.3 Latin America Propofol and Ciprofol Injections Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Propofol and Ciprofol Injections Market Facts & Figures by Country

3.8.1 Middle East and Africa Propofol and Ciprofol Injections Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Propofol and Ciprofol Injections Sales by Country (2021–2032)

3.8.3 Middle East and Africa Propofol and Ciprofol Injections Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Propofol and Ciprofol Injections Sales by Type (2021–2032)

4.1.1 Global Propofol and Ciprofol Injections Sales by Type (2021–2026)

4.1.2 Global Propofol and Ciprofol Injections Sales by Type (2027–2032)

4.1.3 Global Propofol and Ciprofol Injections Sales Market Share by Type (2021–2032)

4.2 Global Propofol and Ciprofol Injections Revenue by Type (2021–2032)

4.2.1 Global Propofol and Ciprofol Injections Revenue by Type (2021–2026)

4.2.2 Global Propofol and Ciprofol Injections Revenue by Type (2027–2032)

4.2.3 Global Propofol and Ciprofol Injections Revenue Market Share by Type (2021–2032)

4.3 Global Propofol and Ciprofol Injections Price by Type (2021–2032)

5 Segment by Application

5.1 Global Propofol and Ciprofol Injections Sales by Application (2021–2032)

5.1.1 Global Propofol and Ciprofol Injections Sales by Application (2021–2026)

5.1.2 Global Propofol and Ciprofol Injections Sales by Application (2027–2032)

5.1.3 Global Propofol and Ciprofol Injections Sales Market Share by Application (2021–2032)

5.2 Global Propofol and Ciprofol Injections Revenue by Application (2021–2032)

5.2.1 Global Propofol and Ciprofol Injections Revenue by Application (2021–2026)

5.2.2 Global Propofol and Ciprofol Injections Revenue by Application (2027–2032)

5.2.3 Global Propofol and Ciprofol Injections Revenue Market Share by Application (2021–2032)

5.3 Global Propofol and Ciprofol Injections Price by Application (2021–2032)

6 Key Companies Profiled

6.1 Fresenius Kabi

6.1.1 Fresenius Kabi Company Information

6.1.2 Fresenius Kabi Description and Business Overview

6.1.3 Fresenius Kabi Propofol and Ciprofol Injections Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 Fresenius Kabi Propofol and Ciprofol Injections Product Portfolio

6.1.5 Fresenius Kabi Recent Developments/Updates

6.2 Pfizer

6.2.1 Pfizer Company Information

6.2.2 Pfizer Description and Business Overview

6.2.3 Pfizer Propofol and Ciprofol Injections Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 Pfizer Propofol and Ciprofol Injections Product Portfolio

6.2.5 Pfizer Recent Developments/Updates

6.3 B. Braun

6.3.1 B. Braun Company Information

6.3.2 B. Braun Description and Business Overview

6.3.3 B. Braun Propofol and Ciprofol Injections Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 B. Braun Propofol and Ciprofol Injections Product Portfolio

6.3.5 B. Braun Recent Developments/Updates

6.4 Sagent Pharmaceuticals

6.4.1 Sagent Pharmaceuticals Company Information

6.4.2 Sagent Pharmaceuticals Description and Business Overview

6.4.3 Sagent Pharmaceuticals Propofol and Ciprofol Injections Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 Sagent Pharmaceuticals Propofol and Ciprofol Injections Product Portfolio

6.4.5 Sagent Pharmaceuticals Recent Developments/Updates

6.5 Dr. Reddy's Laboratories

6.5.1 Dr. Reddy's Laboratories Company Information

6.5.2 Dr. Reddy's Laboratories Description and Business Overview

6.5.3 Dr. Reddy's Laboratories Propofol and Ciprofol Injections Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 Dr. Reddy's Laboratories Propofol and Ciprofol Injections Product Portfolio

6.5.5 Dr. Reddy's Laboratories Recent Developments/Updates

6.6 Rusoma

6.6.1 Rusoma Company Information

6.6.2 Rusoma Description and Business Overview

6.6.3 Rusoma Propofol and Ciprofol Injections Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 Rusoma Propofol and Ciprofol Injections Product Portfolio

6.6.5 Rusoma Recent Developments/Updates

6.7 Centurion Healthcare

6.7.1 Centurion Healthcare Company Information

6.7.2 Centurion Healthcare Description and Business Overview

6.7.3 Centurion Healthcare Propofol and Ciprofol Injections Sales, Revenue, and Gross Margin (2021–2026)

6.7.4 Centurion Healthcare Propofol and Ciprofol Injections Product Portfolio

6.7.5 Centurion Healthcare Recent Developments/Updates

6.8 Wellona Pharma

6.8.1 Wellona Pharma Company Information

6.8.2 Wellona Pharma Description and Business Overview

6.8.3 Wellona Pharma Propofol and Ciprofol Injections Sales, Revenue, and Gross Margin (2021–2026)

6.8.4 Wellona Pharma Propofol and Ciprofol Injections Product Portfolio

6.8.5 Wellona Pharma Recent Developments/Updates

6.9 Hikma Pharmaceuticals

6.9.1 Hikma Pharmaceuticals Company Information

6.9.2 Hikma Pharmaceuticals Description and Business Overview

6.9.3 Hikma Pharmaceuticals Propofol and Ciprofol Injections Sales, Revenue, and Gross Margin (2021–2026)

6.9.4 Hikma Pharmaceuticals Propofol and Ciprofol Injections Product Portfolio

6.9.5 Hikma Pharmaceuticals Recent Developments/Updates

6.10 Avet Pharmaceuticals

6.10.1 Avet Pharmaceuticals Company Information

6.10.2 Avet Pharmaceuticals Description and Business Overview

6.10.3 Avet Pharmaceuticals Propofol and Ciprofol Injections Sales, Revenue, and Gross Margin (2021–2026)

6.10.4 Avet Pharmaceuticals Propofol and Ciprofol Injections Product Portfolio

6.10.5 Avet Pharmaceuticals Recent Developments/Updates

6.11 Xi’an Libang Pharmaceutical

6.11.1 Xi’an Libang Pharmaceutical Company Information

6.11.2 Xi’an Libang Pharmaceutical Description and Business Overview

6.11.3 Xi’an Libang Pharmaceutical Propofol and Ciprofol Injections Sales, Revenue, and Gross Margin (2021–2026)

6.11.4 Xi’an Libang Pharmaceutical Propofol and Ciprofol Injections Product Portfolio

6.11.5 Xi’an Libang Pharmaceutical Recent Developments/Updates

6.12 Guangdong Jiabo Pharmaceutical

6.12.1 Guangdong Jiabo Pharmaceutical Company Information

6.12.2 Guangdong Jiabo Pharmaceutical Description and Business Overview

6.12.3 Guangdong Jiabo Pharmaceutical Propofol and Ciprofol Injections Sales, Revenue, and Gross Margin (2021–2026)

6.12.4 Guangdong Jiabo Pharmaceutical Propofol and Ciprofol Injections Product Portfolio

6.12.5 Guangdong Jiabo Pharmaceutical Recent Developments/Updates

6.13 Sichuan Biokin Pharmaceutical

6.13.1 Sichuan Biokin Pharmaceutical Company Information

6.13.2 Sichuan Biokin Pharmaceutical Description and Business Overview

6.13.3 Sichuan Biokin Pharmaceutical Propofol and Ciprofol Injections Sales, Revenue, and Gross Margin (2021–2026)

6.13.4 Sichuan Biokin Pharmaceutical Propofol and Ciprofol Injections Product Portfolio

6.13.5 Sichuan Biokin Pharmaceutical Recent Developments/Updates

6.14 Sichuan Kelun Pharmaceutical

6.14.1 Sichuan Kelun Pharmaceutical Company Information

6.14.2 Sichuan Kelun Pharmaceutical Description and Business Overview

6.14.3 Sichuan Kelun Pharmaceutical Propofol and Ciprofol Injections Sales, Revenue, and Gross Margin (2021–2026)

6.14.4 Sichuan Kelun Pharmaceutical Propofol and Ciprofol Injections Product Portfolio

6.14.5 Sichuan Kelun Pharmaceutical Recent Developments/Updates

6.15 Jiangsu Nhwa Pharmaceutical

6.15.1 Jiangsu Nhwa Pharmaceutical Company Information

6.15.2 Jiangsu Nhwa Pharmaceutical Description and Business Overview

6.15.3 Jiangsu Nhwa Pharmaceutical Propofol and Ciprofol Injections Sales, Revenue, and Gross Margin (2021–2026)

6.15.4 Jiangsu Nhwa Pharmaceutical Propofol and Ciprofol Injections Product Portfolio

6.15.5 Jiangsu Nhwa Pharmaceutical Recent Developments/Updates

6.16 Jiangsu Yingke Biopharmaceutical

6.16.1 Jiangsu Yingke Biopharmaceutical Company Information

6.16.2 Jiangsu Yingke Biopharmaceutical Description and Business Overview

6.16.3 Jiangsu Yingke Biopharmaceutical Propofol and Ciprofol Injections Sales, Revenue, and Gross Margin (2021–2026)

6.16.4 Jiangsu Yingke Biopharmaceutical Propofol and Ciprofol Injections Product Portfolio

6.16.5 Jiangsu Yingke Biopharmaceutical Recent Developments/Updates

6.17 Haisco Pharmaceutical Group

6.17.1 Haisco Pharmaceutical Group Company Information

6.17.2 Haisco Pharmaceutical Group Description and Business Overview

6.17.3 Haisco Pharmaceutical Group Propofol and Ciprofol Injections Sales, Revenue, and Gross Margin (2021–2026)

6.17.4 Haisco Pharmaceutical Group Propofol and Ciprofol Injections Product Portfolio

6.17.5 Haisco Pharmaceutical Group Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Propofol and Ciprofol Injections Industry Chain Analysis

7.2 Propofol and Ciprofol Injections Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Propofol and Ciprofol Injections Production Mode & Process Analysis

7.4 Propofol and Ciprofol Injections Sales and Marketing

7.4.1 Propofol and Ciprofol Injections Sales Channels

7.4.2 Propofol and Ciprofol Injections Distributors

7.5 Propofol and Ciprofol Injections Customer Analysis

8 Propofol and Ciprofol Injections Market Dynamics

8.1 Propofol and Ciprofol Injections Industry Trends

8.2 Propofol and Ciprofol Injections Market Drivers

8.3 Propofol and Ciprofol Injections Market Challenges

8.4 Propofol and Ciprofol Injections Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Guangdong Jiabo Pharmaceutical

Xi'an Libang Pharmaceutical

Jiangsu Nhwa Pharmaceutical

Haisco Pharmaceutical Group

Sichuan Biokin Pharmaceutical

Fresenius Kabi

Pfizer Inc

Dr. Reddy’s Laboratories

Sichuan Kelun Pharmaceutical

Jiangsu Yingke Biopharmaceutical

Sagent Pharmaceuticals

Hikma Pharmaceuticals

Avet Pharmaceuticals

List of Tables

Table 1. Global Propofol and Ciprofol Injections Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Propofol and Ciprofol Injections Market Value by Concentration (US$ Million), 2025 vs 2032

Table 3. Global Propofol and Ciprofol Injections Market Value by Packaging (US$ Million), 2025 vs 2032

Table 4. Global Propofol and Ciprofol Injections Market Value by Application (US$ Million), 2025 vs 2032

Table 5. Global Propofol and Ciprofol Injections Market Competitive Situation by Manufacturers in 2025

Table 6. Global Propofol and Ciprofol Injections Sales (K Units) of Key Manufacturers (2021–2026)

Table 7. Global Propofol and Ciprofol Injections Sales Market Share by Manufacturers (2021–2026)

Table 8. Global Propofol and Ciprofol Injections Revenue (US$ Million) by Manufacturers (2021–2026)

Table 9. Global Propofol and Ciprofol Injections Revenue Share by Manufacturers (2021–2026)

Table 10. Global Market Propofol and Ciprofol Injections Average Price (US$/Unit) of Key Manufacturers (2021–2026)

Table 11. Global Key Players of Propofol and Ciprofol Injections, Industry Ranking, 2023 vs 2024 vs 2025

Table 12. Global Key Manufacturers of Propofol and Ciprofol Injections, Manufacturing Sites and Headquarters

Table 13. Global Key Manufacturers of Propofol and Ciprofol Injections, Product Types and Applications

Table 14. Global Key Manufacturers of Propofol and Ciprofol Injections, Date of Entry into the Industry

Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 16. Global Propofol and Ciprofol Injections Companies by Tier (Tier 1, Tier 2, Tier 3), based on Propofol and Ciprofol Injections Revenue, 2025

Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 18. Global Propofol and Ciprofol Injections Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 19. Global Propofol and Ciprofol Injections Sales by Region (K Units), 2021–2026

Table 20. Global Propofol and Ciprofol Injections Sales Market Share by Region (2021–2026)

Table 21. Global Propofol and Ciprofol Injections Sales by Region (K Units), 2027–2032

Table 22. Global Propofol and Ciprofol Injections Sales Market Share by Region (2027–2032)

Table 23. Global Propofol and Ciprofol Injections Revenue by Region (US$ Million), 2021–2026

Table 24. Global Propofol and Ciprofol Injections Revenue Market Share by Region (2021–2026)

Table 25. Global Propofol and Ciprofol Injections Revenue by Region (US$ Million), 2027–2032

Table 26. Global Propofol and Ciprofol Injections Revenue Market Share by Region (2027–2032)

Table 27. North America Propofol and Ciprofol Injections Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 28. North America Propofol and Ciprofol Injections Sales by Country (K Units), 2021–2026

Table 29. North America Propofol and Ciprofol Injections Sales by Country (K Units), 2027–2032

Table 30. North America Propofol and Ciprofol Injections Revenue by Country (US$ Million), 2021–2026

Table 31. North America Propofol and Ciprofol Injections Revenue by Country (US$ Million), 2027–2032

Table 32. Europe Propofol and Ciprofol Injections Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 33. Europe Propofol and Ciprofol Injections Sales by Country (K Units), 2021–2026

Table 34. Europe Propofol and Ciprofol Injections Sales by Country (K Units), 2027–2032

Table 35. Europe Propofol and Ciprofol Injections Revenue by Country (US$ Million), 2021–2026

Table 36. Europe Propofol and Ciprofol Injections Revenue by Country (US$ Million), 2027–2032

Table 37. Asia Pacific Propofol and Ciprofol Injections Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 38. Asia Pacific Propofol and Ciprofol Injections Sales by Region (K Units), 2021–2026

Table 39. Asia Pacific Propofol and Ciprofol Injections Sales by Region (K Units), 2027–2032

Table 40. Asia Pacific Propofol and Ciprofol Injections Revenue by Region (US$ Million), 2021–2026

Table 41. Asia Pacific Propofol and Ciprofol Injections Revenue by Region (US$ Million), 2027–2032

Table 42. Latin America Propofol and Ciprofol Injections Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 43. Latin America Propofol and Ciprofol Injections Sales by Country (K Units), 2021–2026

Table 44. Latin America Propofol and Ciprofol Injections Sales by Country (K Units), 2027–2032

Table 45. Latin America Propofol and Ciprofol Injections Revenue by Country (US$ Million), 2021–2026

Table 46. Latin America Propofol and Ciprofol Injections Revenue by Country (US$ Million), 2027–2032

Table 47. Middle East and Africa Propofol and Ciprofol Injections Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 48. Middle East and Africa Propofol and Ciprofol Injections Sales by Country (K Units), 2021–2026

Table 49. Middle East and Africa Propofol and Ciprofol Injections Sales by Country (K Units), 2027–2032

Table 50. Middle East and Africa Propofol and Ciprofol Injections Revenue by Country (US$ Million), 2021–2026

Table 51. Middle East and Africa Propofol and Ciprofol Injections Revenue by Country (US$ Million), 2027–2032

Table 52. Global Propofol and Ciprofol Injections Sales (K Units) by Type (2021–2026)

Table 53. Global Propofol and Ciprofol Injections Sales (K Units) by Type (2027–2032)

Table 54. Global Propofol and Ciprofol Injections Sales Market Share by Type (2021–2026)

Table 55. Global Propofol and Ciprofol Injections Sales Market Share by Type (2027–2032)

Table 56. Global Propofol and Ciprofol Injections Revenue (US$ Million) by Type (2021–2026)

Table 57. Global Propofol and Ciprofol Injections Revenue (US$ Million) by Type (2027–2032)

Table 58. Global Propofol and Ciprofol Injections Revenue Market Share by Type (2021–2026)

Table 59. Global Propofol and Ciprofol Injections Revenue Market Share by Type (2027–2032)

Table 60. Global Propofol and Ciprofol Injections Price (US$/Unit) by Type (2021–2026)

Table 61. Global Propofol and Ciprofol Injections Price (US$/Unit) by Type (2027–2032)

Table 62. Global Propofol and Ciprofol Injections Sales (K Units) by Application (2021–2026)

Table 63. Global Propofol and Ciprofol Injections Sales (K Units) by Application (2027–2032)

Table 64. Global Propofol and Ciprofol Injections Sales Market Share by Application (2021–2026)

Table 65. Global Propofol and Ciprofol Injections Sales Market Share by Application (2027–2032)

Table 66. Global Propofol and Ciprofol Injections Revenue (US$ Million) by Application (2021–2026)

Table 67. Global Propofol and Ciprofol Injections Revenue (US$ Million) by Application (2027–2032)

Table 68. Global Propofol and Ciprofol Injections Revenue Market Share by Application (2021–2026)

Table 69. Global Propofol and Ciprofol Injections Revenue Market Share by Application (2027–2032)

Table 70. Global Propofol and Ciprofol Injections Price (US$/Unit) by Application (2021–2026)

Table 71. Global Propofol and Ciprofol Injections Price (US$/Unit) by Application (2027–2032)

Table 72. Fresenius Kabi Company Information

Table 73. Fresenius Kabi Description and Business Overview

Table 74. Fresenius Kabi Propofol and Ciprofol Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 75. Fresenius Kabi Propofol and Ciprofol Injections Product

Table 76. Fresenius Kabi Recent Developments/Updates

Table 77. Pfizer Company Information

Table 78. Pfizer Description and Business Overview

Table 79. Pfizer Propofol and Ciprofol Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 80. Pfizer Propofol and Ciprofol Injections Product

Table 81. Pfizer Recent Developments/Updates

Table 82. B. Braun Company Information

Table 83. B. Braun Description and Business Overview

Table 84. B. Braun Propofol and Ciprofol Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 85. B. Braun Propofol and Ciprofol Injections Product

Table 86. B. Braun Recent Developments/Updates

Table 87. Sagent Pharmaceuticals Company Information

Table 88. Sagent Pharmaceuticals Description and Business Overview

Table 89. Sagent Pharmaceuticals Propofol and Ciprofol Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 90. Sagent Pharmaceuticals Propofol and Ciprofol Injections Product

Table 91. Sagent Pharmaceuticals Recent Developments/Updates

Table 92. Dr. Reddy's Laboratories Company Information

Table 93. Dr. Reddy's Laboratories Description and Business Overview

Table 94. Dr. Reddy's Laboratories Propofol and Ciprofol Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 95. Dr. Reddy's Laboratories Propofol and Ciprofol Injections Product

Table 96. Dr. Reddy's Laboratories Recent Developments/Updates

Table 97. Rusoma Company Information

Table 98. Rusoma Description and Business Overview

Table 99. Rusoma Propofol and Ciprofol Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 100. Rusoma Propofol and Ciprofol Injections Product

Table 101. Rusoma Recent Developments/Updates

Table 102. Centurion Healthcare Company Information

Table 103. Centurion Healthcare Description and Business Overview

Table 104. Centurion Healthcare Propofol and Ciprofol Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 105. Centurion Healthcare Propofol and Ciprofol Injections Product

Table 106. Centurion Healthcare Recent Developments/Updates

Table 107. Wellona Pharma Company Information

Table 108. Wellona Pharma Description and Business Overview

Table 109. Wellona Pharma Propofol and Ciprofol Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 110. Wellona Pharma Propofol and Ciprofol Injections Product

Table 111. Wellona Pharma Recent Developments/Updates

Table 112. Hikma Pharmaceuticals Company Information

Table 113. Hikma Pharmaceuticals Description and Business Overview

Table 114. Hikma Pharmaceuticals Propofol and Ciprofol Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 115. Hikma Pharmaceuticals Propofol and Ciprofol Injections Product

Table 116. Hikma Pharmaceuticals Recent Developments/Updates

Table 117. Avet Pharmaceuticals Company Information

Table 118. Avet Pharmaceuticals Description and Business Overview

Table 119. Avet Pharmaceuticals Propofol and Ciprofol Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 120. Avet Pharmaceuticals Propofol and Ciprofol Injections Product

Table 121. Avet Pharmaceuticals Recent Developments/Updates

Table 122. Xi’an Libang Pharmaceutical Company Information

Table 123. Xi’an Libang Pharmaceutical Description and Business Overview

Table 124. Xi’an Libang Pharmaceutical Propofol and Ciprofol Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 125. Xi’an Libang Pharmaceutical Propofol and Ciprofol Injections Product

Table 126. Xi’an Libang Pharmaceutical Recent Developments/Updates

Table 127. Guangdong Jiabo Pharmaceutical Company Information

Table 128. Guangdong Jiabo Pharmaceutical Description and Business Overview

Table 129. Guangdong Jiabo Pharmaceutical Propofol and Ciprofol Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 130. Guangdong Jiabo Pharmaceutical Propofol and Ciprofol Injections Product

Table 131. Guangdong Jiabo Pharmaceutical Recent Developments/Updates

Table 132. Sichuan Biokin Pharmaceutical Company Information

Table 133. Sichuan Biokin Pharmaceutical Description and Business Overview

Table 134. Sichuan Biokin Pharmaceutical Propofol and Ciprofol Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 135. Sichuan Biokin Pharmaceutical Propofol and Ciprofol Injections Product

Table 136. Sichuan Biokin Pharmaceutical Recent Developments/Updates

Table 137. Sichuan Kelun Pharmaceutical Company Information

Table 138. Sichuan Kelun Pharmaceutical Description and Business Overview

Table 139. Sichuan Kelun Pharmaceutical Propofol and Ciprofol Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 140. Sichuan Kelun Pharmaceutical Propofol and Ciprofol Injections Product

Table 141. Sichuan Kelun Pharmaceutical Recent Developments/Updates

Table 142. Jiangsu Nhwa Pharmaceutical Company Information

Table 143. Jiangsu Nhwa Pharmaceutical Description and Business Overview

Table 144. Jiangsu Nhwa Pharmaceutical Propofol and Ciprofol Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 145. Jiangsu Nhwa Pharmaceutical Propofol and Ciprofol Injections Product

Table 146. Jiangsu Nhwa Pharmaceutical Recent Developments/Updates

Table 147. Jiangsu Yingke Biopharmaceutical Company Information

Table 148. Jiangsu Yingke Biopharmaceutical Description and Business Overview

Table 149. Jiangsu Yingke Biopharmaceutical Propofol and Ciprofol Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 150. Jiangsu Yingke Biopharmaceutical Propofol and Ciprofol Injections Product

Table 151. Jiangsu Yingke Biopharmaceutical Recent Developments/Updates

Table 152. Haisco Pharmaceutical Group Company Information

Table 153. Haisco Pharmaceutical Group Description and Business Overview

Table 154. Haisco Pharmaceutical Group Propofol and Ciprofol Injections Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 155. Haisco Pharmaceutical Group Propofol and Ciprofol Injections Product

Table 156. Haisco Pharmaceutical Group Recent Developments/Updates

Table 157. Key Raw Materials Lists

Table 158. Raw Materials Key Suppliers Lists

Table 159. Propofol and Ciprofol Injections Distributors List

Table 160. Propofol and Ciprofol Injections Customers List

Table 161. Propofol and Ciprofol Injections Market Trends

Table 162. Propofol and Ciprofol Injections Market Drivers

Table 163. Propofol and Ciprofol Injections Market Challenges

Table 164. Propofol and Ciprofol Injections Market Restraints

Table 165. Research Programs/Design for This Report

Table 166. Key Data Information from Secondary Sources

Table 167. Key Data Information from Primary Sources

Table 168. Authors List of This Report

List of Figures

Figure 1. Product Picture of Propofol and Ciprofol Injections

Figure 2. Global Propofol and Ciprofol Injections Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Propofol and Ciprofol Injections Market Share by Type: 2025 & 2032

Figure 4. Propofol Injections Product Picture

Figure 5. Ciprofol Injections Product Picture

Figure 6. Global Propofol and Ciprofol Injections Market Value by Concentration (US$ Million), 2021–2032

Figure 7. Global Propofol and Ciprofol Injections Market Share by Concentration: 2025 vs 2032

Figure 8. 1% Product Picture

Figure 9. 2% Product Picture

Figure 10. Other Product Picture

Figure 11. Global Propofol and Ciprofol Injections Market Value by Packaging (US$ Million), 2021–2032

Figure 12. Global Propofol and Ciprofol Injections Market Share by Packaging: 2025 vs 2032

Figure 13. 10 mL Product Picture

Figure 14. 20 mL Product Picture

Figure 15. 50 mL Product Picture

Figure 16. 100 mL Product Picture

Figure 17. Global Propofol and Ciprofol Injections Market Value by Application (US$ Million), 2021–2032

Figure 18. Global Propofol and Ciprofol Injections Market Share by Application: 2025 & 2032

Figure 19. General Anesthesia

Figure 20. Medical Procedures Sedation

Figure 21. Mechanical Ventilation

Figure 22. Other

Figure 23. Global Propofol and Ciprofol Injections Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 24. Global Propofol and Ciprofol Injections Market Size (US$ Million), 2021–2032

Figure 25. Global Propofol and Ciprofol Injections Sales (K Units), 2021–2032

Figure 26. Global Propofol and Ciprofol Injections Average Price (US$/Unit), 2021–2032

Figure 27. Propofol and Ciprofol Injections Report Years Considered

Figure 28. Propofol and Ciprofol Injections Sales Share by Manufacturers in 2025

Figure 29. Global Propofol and Ciprofol Injections Revenue Share by Manufacturers in 2025

Figure 30. Top 5 and Top 10 Global Propofol and Ciprofol Injections Players: Market Share by Revenue in Propofol and Ciprofol Injections in 2025

Figure 31. Propofol and Ciprofol Injections Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 32. Global Propofol and Ciprofol Injections Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 33. North America Propofol and Ciprofol Injections Sales Market Share by Country (2021–2032)

Figure 34. North America Propofol and Ciprofol Injections Revenue Market Share by Country (2021–2032)

Figure 35. United States Propofol and Ciprofol Injections Revenue Growth Rate (US$ Million), 2021–2032

Figure 36. Canada Propofol and Ciprofol Injections Revenue Growth Rate (US$ Million), 2021–2032

Figure 37. Europe Propofol and Ciprofol Injections Sales Market Share by Country (2021–2032)

Figure 38. Europe Propofol and Ciprofol Injections Revenue Market Share by Country (2021–2032)

Figure 39. Germany Propofol and Ciprofol Injections Revenue Growth Rate (US$ Million), 2021–2032

Figure 40. France Propofol and Ciprofol Injections Revenue Growth Rate (US$ Million), 2021–2032

Figure 41. U.K. Propofol and Ciprofol Injections Revenue Growth Rate (US$ Million), 2021–2032

Figure 42. Italy Propofol and Ciprofol Injections Revenue Growth Rate (US$ Million), 2021–2032

Figure 43. Russia Propofol and Ciprofol Injections Revenue Growth Rate (US$ Million), 2021–2032

Figure 44. Asia Pacific Propofol and Ciprofol Injections Sales Market Share by Region (2021–2032)

Figure 45. Asia Pacific Propofol and Ciprofol Injections Revenue Market Share by Region (2021–2032)

Figure 46. China Propofol and Ciprofol Injections Revenue Growth Rate (US$ Million), 2021–2032

Figure 47. Japan Propofol and Ciprofol Injections Revenue Growth Rate (US$ Million), 2021–2032

Figure 48. South Korea Propofol and Ciprofol Injections Revenue Growth Rate (US$ Million), 2021–2032

Figure 49. India Propofol and Ciprofol Injections Revenue Growth Rate (US$ Million), 2021–2032

Figure 50. Australia Propofol and Ciprofol Injections Revenue Growth Rate (US$ Million), 2021–2032

Figure 51. China Taiwan Propofol and Ciprofol Injections Revenue Growth Rate (US$ Million), 2021–2032

Figure 52. Southeast Asia Propofol and Ciprofol Injections Revenue Growth Rate (US$ Million), 2021–2032

Figure 53. Latin America Propofol and Ciprofol Injections Sales Market Share by Country (2021–2032)

Figure 54. Latin America Propofol and Ciprofol Injections Revenue Market Share by Country (2021–2032)

Figure 55. Mexico Propofol and Ciprofol Injections Revenue Growth Rate (US$ Million), 2021–2032

Figure 56. Brazil Propofol and Ciprofol Injections Revenue Growth Rate (US$ Million), 2021–2032

Figure 57. Argentina Propofol and Ciprofol Injections Revenue Growth Rate (US$ Million), 2021–2032

Figure 58. Middle East and Africa Propofol and Ciprofol Injections Sales Market Share by Country (2021–2032)

Figure 59. Middle East and Africa Propofol and Ciprofol Injections Revenue Market Share by Country (2021–2032)

Figure 60. Turkey Propofol and Ciprofol Injections Revenue Growth Rate (US$ Million), 2021–2032

Figure 61. Saudi Arabia Propofol and Ciprofol Injections Revenue Growth Rate (US$ Million), 2021–2032

Figure 62. UAE Propofol and Ciprofol Injections Revenue Growth Rate (US$ Million), 2021–2032

Figure 63. Global Sales Market Share of Propofol and Ciprofol Injections by Type (2021–2032)

Figure 64. Global Revenue Market Share of Propofol and Ciprofol Injections by Type (2021–2032)

Figure 65. Global Propofol and Ciprofol Injections Price (US$/Unit) by Type (2021–2032)

Figure 66. Global Sales Market Share of Propofol and Ciprofol Injections by Application (2021–2032)

Figure 67. Global Revenue Market Share of Propofol and Ciprofol Injections by Application (2021–2032)

Figure 68. Global Propofol and Ciprofol Injections Price (US$/Unit) by Application (2021–2032)

Figure 69. Propofol and Ciprofol Injections Value Chain

Figure 70. Channels of Distribution (Direct Vs Distribution)

Figure 71. Bottom-up and Top-down Approaches for This Report

Figure 72. Data Triangulation

Figure 73. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions